$27.52
-0.83-2.93%
At close: -
$27.52
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Latest news for Apellis Pharmaceuticals (NASDAQ:APLS) Stock
Apellis Pharmaceuticals Stock (NASDAQ: APLS)
Categories: All
Thursday, February 20, 2025
Thursday, February 13, 2025
Wednesday, January 29, 2025
Monday, January 27, 2025
Tuesday, January 21, 2025
Tuesday, January 14, 2025
Monday, January 13, 2025
Tuesday, December 17, 2024
- Apellis Pharmaceuticals shares are trading lo...
- Mama's Creations Posts Weak Earnings, Joins EVgo, Red Cat Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
- This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
- Deep Dive Into Apellis Pharmaceuticals Stock: Analyst Perspectives (20 Ratings)
- Goldman Sachs Downgrades Apellis Pharmaceutic...
Thursday, November 21, 2024
Tuesday, November 19, 2024
Thursday, November 07, 2024
Wednesday, November 06, 2024
- Citigroup Maintains Buy on Apellis Pharmaceut...
- Goldman Sachs Maintains Buy on Apellis Pharma...
- RBC Capital Maintains Sector Perform on Apell...
- Scotiabank Maintains Sector Perform on Apelli...
- Wells Fargo Maintains Equal-Weight on Apellis...
- Oppenheimer Maintains Outperform on Apellis P...
- Piper Sandler Maintains Neutral on Apellis Ph...
- Lululemon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
- HC Wainwright & Co. Maintains Buy on Apellis ...
- B of A Securities Maintains Buy on Apellis Ph...
- Needham Maintains Buy on Apellis Pharmaceutic...
Tuesday, November 05, 2024
- Apellis Pharmaceuticals shares are trading lo...
- Celanese Posts Downbeat Results, Joins Cirrus Logic, Teradata And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
- Apellis Pharmaceuticals Reports Cash And Cash...
- Apellis Pharmaceuticals Q3 2024 GAAP EPS $(0....
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Monday, November 04, 2024
Monday, October 28, 2024
Thursday, October 24, 2024
Wednesday, October 16, 2024
- Navigating 18 Analyst Ratings For Apellis Pharmaceuticals
- Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
- Scotiabank Initiates Coverage On Apellis Phar...
- William Blair Initiates Coverage On Apellis P...
- Apellis Announces Oral Presentation On Phase ...